| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.72 | 0.005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |